
Psilocin shows early promise in Entropy’s eating disorder trial
Eating disorders has become a major health concern in Australia and globally, with 1.1m, or 4.45% of Australians living with an eating disorder in 2023, up by 21% since 2012Entropy investigating whether its novel…
Read report ↗





